心肌保護系統市場規模、佔有率和成長分析：按產品類型、手術類型、最終用戶、應用和地區分類－2026年至2033年產業預測

2024 年全球心肌保護系統市場價值為 12.8 億美元，預計到 2025 年將成長至 13.8 億美元，到 2033 年將成長至 24.8 億美元，在預測期（2026-2033 年）內複合年成長率為 7.6%。

全球心肌保護系統市場涵蓋旨在保護心血管手術期間心肌的產品和耗材。這包括心臟驟心臟麻痹液、輸液裝置和監測設備，這些設備對於降低手術全期死亡率和改善搭橋手術和瓣膜置換術等手術的長期患者預後至關重要。市場正從基礎的低溫晶體灌注方法轉向具有代謝監測功能的先進溫控灌注系統。推動這一轉變的因素包括冠狀動脈疾病發生率的上升、人口老化以及創新外科技術的引入。個人化的心臟麻痹方案能夠根據患者的風險狀況進行客製化治療，從而推動市場成長。對生物工程灌注液的大量投資進一步改善了器官保存和手術效果，同時也刺激了對先進監測技術的需求，尤其是在新興的亞太市場。

全球心肌眼保護系統市場的成長要素

全球心血管手術數量的成長導致需要心肌保護的患者群體顯著擴大，促使醫療機構採用最先進的保護系統。醫療專業人員認知到，有效的心肌保護可以最大限度地減少術中缺血性損傷，改善術後恢復，並縮短患者在加護病房的住院時間。這種毋庸置疑的臨床益處影響著醫院的採購決策，並激勵製造商不斷創新，加強分銷管道，從而促進不同醫療機構的市場成長。此外，這些保護系統與先進的微創手術技術的協同作用提高了手術效率，進一步鼓勵手術團隊採用這些技術，以追求更高的病人安全性和更最佳化的資源管理。

全球心肌眼保護系統市場面臨的限制因素

心肌保護裝置相關的財務負擔（包括購買成本、維護成本以及必要的人員培訓成本等）是醫療機構，尤其是資源匱乏地區醫療機構面臨的主要障礙。管理者常常需要在有限的預算內平衡各項優先事項，例如人員配置、基礎設施改善和其他關鍵醫療技術。因此，決策者可能會選擇推遲或限制先進心肌保護系統的部署，轉而選擇成本更低的替代方案，甚至完全推遲部署。這種趨勢阻礙了市場成長，並妨礙了此類裝置在各種臨床環境中的廣泛應用。此外，長期成本效益的不確定性也使得投資猶豫不決，導致採購部門在財務方面更加謹慎。

全球心肌眼保護系統市場趨勢

全球心肌保護系統市場正經歷著向精準成像技術融合的顯著變革，從而改善手術方案和治療效果。高解析度螢光成像和即時磁振造影等先進的術中成像技術正被應用於心肌保護策略。這種融合能夠即時顯示灌注區域，並可根據心肌組織的特定代謝需求，輸注個人化的心臟麻痹液。因此，缺血性損傷顯著減少，體外循環時間縮短。醫療設備製造商正加強與影像公司的合作，建立整合系統，以簡化微創手術的工作流程，最終提高手術效率和患者照護。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球心肌眼保護系統市場規模：依產品類型分類

• 心臟麻痹誘導輸液系統
• 心肌溫度管理系統
• 心肌保護配件

全球心肌眼保護系統市場規模：依治療類型分類

• 成人心臟血管外科
• 兒童心血管外科

全球心肌眼保護系統市場規模：依最終用戶分類

• 醫院
• 心臟中心
• 門診手術中心

全球心肌眼保護系統市場規模：依應用領域分類

• 冠狀動脈繞道手術手術（CABG）
• 心臟瓣膜手術
• 心臟移植
• 其他心臟治療

全球心肌眼保護系統市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• LivaNova PLC
• Getinge AB
• Medtronic plc
• Terumo Corporation
• Edwards Lifesciences Corporation
• Abbott Laboratories
• Johnson & Johnson
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Braile Biomedica Industria, Comercio e Representacoes Ltda.
• MicroPort Scientific Corporation
• Nipro Corporation
• Lepu Medical Technology（Beijing）Co., Ltd.
• Xeltis BV
• CytoSorbents Corporation
• AtriCure, Inc.
• Teleflex Incorporated
• Sorin Group Italia Srl
• Meril Life Sciences Pvt. Ltd.
• Cardia, Inc.

結論與建議

Global Myocardial Protection System Market size was valued at USD 1.28 Billion in 2024 and is poised to grow from USD 1.38 Billion in 2025 to USD 2.48 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global myocardial protection system market comprises products and consumables aimed at safeguarding the heart muscle during cardiac procedures. This encompasses cardioplegic solutions, delivery devices, and monitoring equipment, essential for decreasing peri-operative mortality and enhancing long-term patient outcomes in surgeries like bypass and valve replacements. The market has shifted from basic cold crystalloid methods to sophisticated temperature-controlled perfusion systems with metabolic monitoring capabilities. This transformation is influenced by rising coronary artery disease rates, an aging population, and the adoption of innovative surgical techniques. Personalized cardioplegia protocols are advancing market growth, enabling customized treatment based on patient risk profiles. Significant investments in bioengineered perfusates further enhance organ preservation, improve surgical outcomes, and stimulate demand for advanced monitoring technologies, particularly in emerging Asia-Pacific markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Myocardial Protection System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Myocardial Protection System Market Segments Analysis

Global myocardial protection system market is segmented by product type, procedure type, end user, application and region. Based on product type, the market is segmented into cardioplegia delivery systems, myocardial temperature management systems and myocardial protection accessories. Based on procedure type, the market is segmented into adult cardiac surgery and pediatric cardiac surgery. Based on end user, the market is segmented into hospitals, cardiac centers and ambulatory surgical centers. Based on application, the market is segmented into coronary artery bypass grafting (CABG), heart valve surgery, heart transplantation and other cardiac procedures. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Myocardial Protection System Market

The increase in cardiac surgeries globally is significantly broadening the patient demographic requiring myocardial protection, leading healthcare facilities to implement cutting-edge protection systems. Medical professionals understand that effective myocardial protection can minimize intraoperative ischemic damage, enhance recovery outcomes, and reduce the length of intensive care admissions. This undeniable clinical benefit influences hospitals' purchasing choices, motivating manufacturers to innovate and enhance distribution channels, which contributes to market growth across various healthcare environments. Moreover, the synergistic integration of these protection systems with progressive minimally invasive methods improves procedural efficacy, which further encourages surgical teams to adopt these technologies in pursuit of better patient safety and optimal resource management.

Restraints in the Global Myocardial Protection System Market

The financial implications associated with myocardial protection devices, including their purchase, upkeep, and the necessary training for staff, create significant barriers for healthcare facilities, especially in areas with limited resources. Administrators often face the challenge of managing constrained budgets while juggling various priorities such as staffing needs, infrastructure improvements, and other vital medical technologies. As a result, decision-makers may choose to defer or restrict the acquisition of advanced myocardial protection systems, opting instead for lower-cost alternatives or postponing their implementation altogether. This trend hampers market growth and hinders widespread integration into different clinical environments. Furthermore, the uncertainty about long-term cost-effectiveness deters investments, increasing financial prudence among procurement groups.

Market Trends of the Global Myocardial Protection System Market

The Global Myocardial Protection System market is witnessing a significant shift towards precision imaging integration, enhancing surgical protocols and outcomes. Advanced intra-operative imaging technologies, including high-resolution fluorescence and real-time MRI, are now being embedded into myocardial protection strategies. This integration allows for immediate visualization of perfusion territories, enabling customized cardioplegia delivery that aligns with the specific metabolic needs of cardiac tissues. As a result, there is a notable reduction in ischemic injury and improvement in bypass times. Device manufacturers are increasingly collaborating with imaging firms to create unified systems that streamline workflows in minimally invasive surgeries, ultimately boosting procedural efficiency and patient care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Myocardial Protection System Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Cardioplegia Delivery Systems
• Myocardial Temperature Management Systems
• Myocardial Protection Accessories

Global Myocardial Protection System Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Adult Cardiac Surgery
• Pediatric Cardiac Surgery

Global Myocardial Protection System Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

Global Myocardial Protection System Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Artery Bypass Grafting (CABG)
• Heart Valve Surgery
• Heart Transplantation
• Other Cardiac Procedures

Global Myocardial Protection System Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, End User, Application)
  • US
  • Canada
• Europe (Product Type, Procedure Type, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, End User, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica Industria, Comercio e Representacoes Ltda.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xeltis B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group Italia S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations